Facebook
Twitter
LinkedIn
ForwardTitle
Category
Credits
Event date
Cost
- LivDerm
- TME
- AMA PRA Category 1 Credit™
- ANCC
- Participation
$0.00
Timely and adequate treatment of atopic dermatitis (AD) is essential for helping to promote better long-term outcomes and quality of life and may help prevent the development of other atopic conditions.
- LivDerm
- TME
- AAPA Category I CME
- AMA PRA Category 1 Credit™
- ANCC
- Participation
$0.00
Pediatric patients with melanin-rich skin, or skin of color (SOC), can be disproportionately affected by numerous dermatologic conditions. Patients can be more susceptible or have a greater disease burden, especially with conditions such as acne, atopic dermatitis, psoriasis, pigmentary disorders, and hair disorders.
- LivDerm
- TME
- AAPA Category I CME
- AMA PRA Category 1 Credit™
- ANCC
- Participation
$0.00
In the United States, a rare disease is defined as a condition that affects fewer than 200,000 people in the US. While each rare disease may not seem to affect so many people, there may be as many as 7,000 rare diseases affecting an estimated 25-30 million Americans. More specifically, there over 1,000 rare skin diseases that are often an extreme burden to the collective many of patients affected by these conditions.
- LivDerm
- TME
- ACPE Pharmacy
- AMA PRA Category 1 Credit™
- ANCC
- Participation
$0.00
Psoriatic arthritis (PsA) is a chronic, debilitating inflammatory disease that is associated with several comorbidities and often antecedes psoriasis. In fact, according to data from the National Psoriasis Foundation (NPF), approximately 30% of people with psoriasis develop PsA, with symptoms appearing around 10 years after the occurrence of cutaneous symptoms.
- CMHC
- ACPE Pharmacy
- AMA PRA Category 1 Credit™
- ANCC
- CDE
- Participation
$0.00
Lowering LDL-C effectively and safely is paramount to prevent and lower the risk of recurrent ASCVD events. Even with the advances in LDL-C lowering therapy, LDL-C goal achievement is low, and clinical inertia and patient non-adherence are major factors for continued ASCVD residual risk. The landscape of LDL-C lowering therapy is rapidly evolving, with several new and emerging agents that may help address these gaps.
- CMHC
- TME
$0.00
The increasing prevalence and impacts of overweight and obesity in patients with type 2 diabetes renders weight loss and weight loss maintenance an important part of treatment goals. In this 6-part webcast series, chaired by Robert H. Eckel, MD and Donna Ryan, MD, you will have a chance to hear from experts on the comprehensive management of obesity in patients with type 2 diabetes, including lifestyle modifications, the spectrum of pharmacotherapy and metabolic surgery, as well as how to practically apply these concepts to patient care.
- PAINWeek
- AANP
- ACCME (All Other)
- ACCME (MD/DO Only)
- ACPE Pharmacy
- ANCC
- APA
$899.00
PAINWeek Digital All Access is an online library of sessions from the PAINWeek Conference that you can watch anytime, anywhere. Plus, every session is certified for credit.It’s great for people who had to miss the meeting, or for those who have attended but couldn't fit every desired session into their schedule.
- PAINWeek
- AAFP
- AANP
- ACCME (All Other)
- ACCME (MD/DO Only)
- ACPE Pharmacy
- ANCC
- APA
$499.00
The enormity of CNS-related conditions poses an immense burden to public health. In 2022, there remain significant knowledge gaps among clinicians treating neurologic and psychiatric disorders. Conditions such as dementia, epilepsy, migraine, MS, and stroke require a more inclusive approach to continuing medical education.The BRAINWeek 2022 Digital All Access agenda has been crafted to address the most frequently diagnosed conditions encountered in clinical practice, with an emphasis on collaborative care among specialists and frontline practitioners.
- CMHC
- ACPE Pharmacy
- AMA PRA Category 1 Credit™
- ANCC
- CDE
- Participation
$0.00
Expert faculty developed three challenging cases that illustrate practical points about the current challenges of optimizing LDL-C lowering therapy, as well as how to optimize treatment with statin and non-statin therapies. In addition, the cases serve to offer clinical pearls on how the newer therapies fit into the treatment landscape and inform patient selection. During the webcast, expert faculty engage in interactive discussions to offer additional perspectives and clinical pearls.
- CMHC
- ACPE Pharmacy
- AMA PRA Category 1 Credit™
- ANCC
- CDE
- Participation
$0.00
Expert faculty developed challenging cases to illustrate practical points in the optimization of LDL-C therapy post-MI, including, but not limited to the points illustrated below. At the end of each case, faculty engage in discussions to offer clinical pearls and expert insights on the cases.